J U Holle, T Kubacki, P Aries, B Hellmich, A Kernder, C Kneitz, P Lamprecht, J H Schirmer, A Schreiber, P Berlit, T A Bley, S Blödt, L Decker, K de Groot, S Engel, I Jordans, B Frye, M Haubitz, K Holl-Ulrich, I Kötter, M Laudien, K Milger-Kneidinger, C Muche-Borowski, U Müller-Ladner, T Neß, B Nölle, E Reinhold-Keller, N Ruffer, K Scheuermann, N Venhoff, S von Vietinghoff, T Wiech, M Zänker, F Moosig
{"title":"[anca相关血管炎的诊断和治疗:德国风湿病和临床免疫学学会S3指南的简短版本e. V.](DGRh)和德国内科学会e. V。(DGIM),德国肾脏学会e. V.;(DGfN),德国耳鼻咽喉和头颈外科学会e. V。(DGHNO-KHC),德国眼科学会e. V.;(DOG),德国神经学会e. V.;(DGN),德国肺炎和呼吸医学学会e. V。(DGP),德国病理学会e. V.;(DGP),德国放射学会,医学放射学会e. V。(DRG),德国病理学家联邦协会,德国肾脏协会e. V。,德国风湿病联盟联邦协会e. V.]","authors":"J U Holle, T Kubacki, P Aries, B Hellmich, A Kernder, C Kneitz, P Lamprecht, J H Schirmer, A Schreiber, P Berlit, T A Bley, S Blödt, L Decker, K de Groot, S Engel, I Jordans, B Frye, M Haubitz, K Holl-Ulrich, I Kötter, M Laudien, K Milger-Kneidinger, C Muche-Borowski, U Müller-Ladner, T Neß, B Nölle, E Reinhold-Keller, N Ruffer, K Scheuermann, N Venhoff, S von Vietinghoff, T Wiech, M Zänker, F Moosig","doi":"10.1007/s00393-024-01596-7","DOIUrl":null,"url":null,"abstract":"<p><p>Vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA) is a rare disease with a potentially severe course. Affected patients should be diagnosed as quickly as possible and given suitable treatment according to the current study situation. Considerable progress has been made in the treatment of this disease in recent years, so that a largely evidence-based therapy with immunosuppressants and biologics is now possible. The guideline on the diagnosis and treatment of ANCA-associated vasculitis was raised from S1 level (2017) to S3 level. This guideline is the first German guideline on the diagnosis and treatment of ANCA-associated vasculitis at S3 level.</p>","PeriodicalId":23834,"journal":{"name":"Zeitschrift fur Rheumatologie","volume":"84 3","pages":"225-251"},"PeriodicalIF":0.9000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Diagnosis and treatment of ANCA-associated vasculitis : SHORT VERSION of the S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for Otorhinolaryngology and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]\",\"authors\":\"J U Holle, T Kubacki, P Aries, B Hellmich, A Kernder, C Kneitz, P Lamprecht, J H Schirmer, A Schreiber, P Berlit, T A Bley, S Blödt, L Decker, K de Groot, S Engel, I Jordans, B Frye, M Haubitz, K Holl-Ulrich, I Kötter, M Laudien, K Milger-Kneidinger, C Muche-Borowski, U Müller-Ladner, T Neß, B Nölle, E Reinhold-Keller, N Ruffer, K Scheuermann, N Venhoff, S von Vietinghoff, T Wiech, M Zänker, F Moosig\",\"doi\":\"10.1007/s00393-024-01596-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA) is a rare disease with a potentially severe course. Affected patients should be diagnosed as quickly as possible and given suitable treatment according to the current study situation. Considerable progress has been made in the treatment of this disease in recent years, so that a largely evidence-based therapy with immunosuppressants and biologics is now possible. The guideline on the diagnosis and treatment of ANCA-associated vasculitis was raised from S1 level (2017) to S3 level. This guideline is the first German guideline on the diagnosis and treatment of ANCA-associated vasculitis at S3 level.</p>\",\"PeriodicalId\":23834,\"journal\":{\"name\":\"Zeitschrift fur Rheumatologie\",\"volume\":\"84 3\",\"pages\":\"225-251\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zeitschrift fur Rheumatologie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00393-024-01596-7\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift fur Rheumatologie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00393-024-01596-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/2 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
[Diagnosis and treatment of ANCA-associated vasculitis : SHORT VERSION of the S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for Otorhinolaryngology and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.]
Vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA) is a rare disease with a potentially severe course. Affected patients should be diagnosed as quickly as possible and given suitable treatment according to the current study situation. Considerable progress has been made in the treatment of this disease in recent years, so that a largely evidence-based therapy with immunosuppressants and biologics is now possible. The guideline on the diagnosis and treatment of ANCA-associated vasculitis was raised from S1 level (2017) to S3 level. This guideline is the first German guideline on the diagnosis and treatment of ANCA-associated vasculitis at S3 level.
期刊介绍:
Die Zeitschrift für Rheumatologie ist ein international angesehenes Publikationsorgan und dient der Fortbildung von niedergelassenen und in der Klinik tätigen Rheumatologen. Die Zeitschrift widmet sich allen Aspekten der klinischen Rheumatologie, der Therapie rheumatischer Erkrankungen sowie der rheumatologischen Grundlagenforschung.
Umfassende Übersichtsarbeiten zu einem aktuellen Schwerpunktthema sind das Kernstück jeder Ausgabe. Im Mittelpunkt steht dabei gesichertes Wissen zu Diagnostik und Therapie mit hoher Relevanz für die tägliche Arbeit – der Leser erhält konkrete Handlungsempfehlungen.
Frei eingereichte Originalien ermöglichen die Präsentation wichtiger klinischer Studien und dienen dem wissenschaftlichen Austausch.